Monday to Sunday: 24/7 Hours Service
Rajiv Gandhi Cancer Institute & Research Centre Book an Appointment
alarm Emergency Book an Appointment Find a Doctor
Doctor Image

Dr. Manoj Gupta

MBBS, DRM, FEBNM, FANMB, Ph.D. {Fellow clinical Nuclear Medicine (Germany)}

Sr. Consultant – Nuclear Medicine

Book an Appointment

RGCIRC, Rohini, Delhi - 110 085

About

Dr. Manoj Gupta is European Board of Nuclear Medicine (FEBNM) Sweden and Asian Nuclear Medicine Board (FANMB) China certified specialist. He has the unique distinction of establishing the first PET CT in Sri Lanka. He did his MBBS from UCMS, Delhi (2000 batch) and Post-Graduation in Nuclear Medicine from renowned Institute in Nuclear Medicine and Allied Sciences (INMAS) Delhi. He also did his Ph.D. in Radiation Biology on ‘Role of Radio-Ligand in Theragnostics of Metastatic Castration Resistant Prostate cancer’. He had advanced training in clinical Nuclear Medicine and radionuclide therapy during his fellowship in RWTH, Aachen, Germany. He has presented his research work on PET-CT in oncology and radionuclides therapies in various national and international forums. He is a recipient of Asian Regional Cooperative Council of Nuclear Medicine (ARCCNM) young scientist grant awards continuously in 2009, 2010, 2012, 2013 and 2016. He also received Merit Award, Selected poster presentation in ESMO Targeted Anticancer Therapies Congress (TAT) 2019, Paris, France, and Travel award in 5th Theranostic World Congress (TWC) 2019, Jeju Korea. He has published many research papers in both national and International peer reviewed journals. He is also a reviewer of many well know journals e.g. European Journal of Radiology, British Journal of case reports and Nuclear Medicine and Molecular Imaging etc. He received the best publication award (P. S. Raman memorial award) of RGCIRC 2018. His keenness in the field of Nuclear Oncology has brought him to RGCIRC and he is working as Consultant since June 2013.

Specialized Areas

  • 18F-FDG PET-CT
  • 68Ga-DOTANOC PET-CT
  • 68Ga-PSMA PET-CT
  • 18F-FES PET-CT
  • 18F-MISO PET-CT
  • 68Ga-FAPi PET-CT
  • 68Ga-PD-L1 PET-CT
  • 68Ga-Trivehexin PET-CT
  • 177Lu-DOTATATE (PRRT)
  • 177Lu-PSMA (PRLT)
  • 225Ac-PSMA/DOTATATE
  • TARE
  • Liver functional Volumetry

Educational Background

  • MBBS (2000-2005), UCMS, Delhi
  • DRM (2006-2008), INMAS, Delhi
  • RSO II (2012), BARC, Mumbai
  • FEBNM (2014), Sweden
  • FANMB (2016), China
  • Ph.D. Radiation Biology (2021)

Experience

  • Sr. Resident, Nuclear Medicine Department, RGCIRC, Delhi: 2008 – 2010
  • Sr. Resident, Dept of Nuclear Medicine and PET-CT, Sir Ganga Ram Hospital, Delhi: 2010-2011
  • Consultant and Head, Department of Nuclear Medicine and PET-CT, ASIRI Surgical Hospital PLC, Colombo, Sri Lanka: 2011-2013
  • Consultant, Nuclear Medicine Department, RGCIRC, Delhi: 2013 – 2022
  • Sr. Consultant, Nuclear Medicine Department, RGCIRC, Delhi: 2022 – till date 

Professional Journey

  • Fellow European Board of Nuclear Medicine (FEBNM) Sweden.
  • Fellow Asian Nuclear Medicine Board (FANMB) China.
  • Established first PET-CT of Sri Lanka in ASIRI surgical Hospital, Colombo.
  • Credit to established protocol of PRRT and PRLT in the department.
  • Radiological Safety Officer II (Nuclear Medicine) Certificate by RPAD, BARC, 2012.
  • Clinical Nuclear Medicine Fellowship, RWTH, Aachen, Germany
  • Ph.D. in Radiation Biology (2021)

Awards

  • ARCCNM young scientist award for distinguished research in 2009, 2010, 2012, 2013 and 2016.
  • Best poster award in ARCCNM and SNMMI annual conference 2013, Mumbai, India.
  • Merit Award, Selected poster presentation in TAT 2019, Paris, France.
  • Travel award in 5th TWC 2019, Jeju Korea
  • Best Publication award of RGCIRC 2018
  • Chairman’s award RGCIRC 2024

Fellowship and trainings

  • Training of “Liver functional volumetry” at Academic Medical Center, Amsterdam (AMC), The Netherlands, under Prof. dr. R. J. Bennink, 2017.
  • Clinical Fellowship in “Nuclear Medicine – Clinical and Translational Program” at The University Hospital Aachen, Germany, under Prof. Dr. med. Felix M. Mottaghy, 2018 (4 weeks).
  • The European Society of Medical Oncology (ESMO) advanced course on clinical questions in prostate cancer’ in Singapore, 6-7 September 2019.
  • Hybrid PET Imaging Course at the Department of Nuclear Medicine at the University Hospital of Zurich, Switzerland July 1, 2024 – July 5, 2024

Publications

  • Gupta M, Choudhury PS, Nag S, Gupta P. An original case of lip metastasis, from non small cell lung cancer. Hell J Nucl Med 2010;13:173-174.
  • Gupta M, Choudhary PS, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med 2014;29:38-39.
  • Gupta M, Choudhury PS, Nag S, Gupta P. Stimulated high serum thyroglobulin with negative whole body imaging do not warrant an aggressive diagnostic and therapeutic approach in differentiated thyroid cancer patients: A follow-up of 5 years or till recurrence. Hellinic Journal of Nuclear Medicine 2015;18:207-214.
  • Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid stimulating hormone levels. Indian J Nucl Med 2015;30:16-20.
  • Gupta M, Choudhury PS, Dsouza M, Louis R, Datta A, Mishra A. 18F-FES PET-CT Scan turns out a problem solving modality in an ER positive metastatic breast cancer patient. American Journal of Cancer Case Reports 2015,3:215-220.
  • Chauhan D, Rawat S, Sharma MK, Ahlawat P, Pal M, Gupta G, et al. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas. J Can Res Ther 2015;11:746-51.
  • Gupta M, Choudhury PS, Gupta G, Gandhi J. Metastasis in urothelial carcinoma mimicking prostate cancer metastasis in Ga-68 prostate-specific membrane antigen positron emission tomography-computed tomography in a case of synchronous malignancy. Indian J Nucl Med 2016;31:222-4.
  • Dewan A, Sharma SK, Dewan AK, Khurana R, Gupta M,Pahuja A, et al. Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus. J Gastrointest Cancer. 2017;48:42-49.
  • Gupta M, Datta A, Choudhury PS, Dsouza M, Batra U, Mishra A. Can 18F-Fluoroestradiol positron emission tomography become a new imaging standard in the estrogen receptorpositive breast cancer patient: A prospective comparative study with 18F-Fluorodeoxyglucose positron emission tomography?. World J Nucl Med 2017;16:133-9.
  • Gupta M, Choudhury PS, Singh S, Mehta A. Exceptional Therapeutic Outcome of Metastatic Neuroendocrine Tumor with Peptide Receptor Radionuclide Therapy with Brief Review of Literature. J Nucl Med Radiat Ther 2017;8:333. doi:10.4172/2155-9619.1000333
  • Gupta M, Choudhury P S, Hazarika D, Rawal S. A Comparative Study of 68Gallium-Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography and Magnetic Resonance Imaging for Lymph Node Staging in High Risk Prostate Cancer Patients: An Initial Experience. World J Nucl Med 2017;16:186-91.
  • Choudhury P, Gupta M. Dual Target Molecular Imaging in precision management of breast cancer: The time has come Medical Research Archives, Vol. 5, Issue 9, September 2017.
  • Gupta M, Choudhury PS, Goel HC, Rawal S, Talwar V (2017) Is PSMA PET-CT Better than Bone Scan? When and Why? J Nucl Med Radiat Ther. 2017,8: 342. doi:10.4172/2155-9619.1000342.
  • Choudhury P, Gupta M. Personalized & Precision Medicine in Cancer: A Theranostic Approach. Curr Radiopharm.2017 Nov 10;10(3):166-170.
  • Gupta M, Choudhury PS, Rawal S, Gupta G. Incremental value of 68-gallium-prostate-specifi c membrane antigen positron emission tomography/computed tomography in patients with abnormal prostate-specific antigen and benign transrectal ultrasound biopsy. Urol Ann. 2018; 10(2):150-153.
  • Tanwar P, Gandhi JS, Sharma A, Gupta M, Choudhary PS. Unusual metastasis of medullary thyroid carcinoma to the breast: A cytological and histopathological correlation. J Cytol 2018 April-June;35:117-20.
  • Agrawal CR, Dutta K, Doval DC, Pasricha S, Gupta M. Breast cancer recurrence presenting as solitary intraparotid nodal metastasis detected by 18F-Fluorodeoxyglucose positron emission tomography: A very unusual occurrence. Indian J Nucl Med 2018 July-Sept;33:233-6.
  • Gupta M, Choudhury PS, Rawal S, Goel HC, Singh A, Talwar V, et al. Initial risk stratification and staging in prostate cancer with prostatic specific membrane antigen PET/CT: A first-stop-shop. World J Nucl Med 2018 Oct-Dec;17:261-269
  • Gupta M, Choudhury PS, Singh S, Hazarika D. Liver functional volumetry by Tc‑99m Mebrofenin hepatobiliary scintigraphy before major liver resection: A game changer. Indian J Nucl Med 2018 Oct-Dec;33:277-283
  • Gupta M, Choudhury PS, Rawal S, Goel HC, Rao SA. Evaluation of RECIST, PERCIST, EORTC and MDA criteria for assessing treatment response with Ga68-PSMA PET-CT in metastatic prostate cancer patient with biochemical progression: A comparative study. Nucl Med Mol Imaging 2018;52:420.
  • Gupta M, Choudhury PS, Rawal S, Goel HC, Rao SA. Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography. Urol Ann 2019;11:155-62.
  • M Gupta, P S Choudhury, S Rawal, H C Goel, V Talwar, K D Dutta, A Singh. 9P Safety profile and therapeutic efficacy of one cycle of [177Lu]prostate-specific membrane antigen (PSMA) in end stage metastatic castration-resistant prostate cancer patients with low performance status. Annals of Oncology, 2019; 30, Issue Supplement_1, February 2019. org/10.1093/annonc/mdz029.002.
  • Gupta, M., Choudhury, P.S., Rawal, S. et al. Safety Profile and Therapeutic Efficacy of One Cycle of Lu177-PSMA in End-Stage Metastatic Castration-Resistant Prostate Cancer Patients with Low Performance Status. Nucl Med Mol Imaging. 2019.53,423-431.
  • Sharma M, Goyal S, Gupta M, Batra U, Jajodia A, Babu VP. A rare case of cardiac metastasis from non-small cell lung cancer. J Indian coll cardiol 2019;9:50-1.
  • Shrestha R, Tripathi R, Goyal P, Agarwal C, Gupta M, Mehta A, et al. Long-Term Survival in an Esophageal Cancer Patient with Multiple Recurrences. Journal of gastrointestinal cancer. 2020,51,695-697.
  • Sharma M, Babu VP, Goyal S, Durga G, Gupta M, Gupta N. Primary Squamous Cell Carcinoma of Stomach: A Rare PresentationAsian Journal of Oncology 2020; 6(01): 32-34. DOI: 10.1055/s-0040-1701392.
  • Gupta M, Choudhury PS, Premsagar IC, Gairola M, Ahlawat P. Role of 68Ga-Prostate-Specific Membrane Antigen PET/CT in Disease Assessment in Glioblastoma Within 48 Hours of Surgery. Clin Nucl Med. 2020 Mar;45:204-205.
  • Gupta M, Choudhury PS, Gairola M, Premsagar IC, Rao SA. Pseudo-progression on 68Ga-Prostate Specific Membrane Antigen-11 PET/CT in a treated glioblastoma. Clin Nucl Med. 2020 Aug;45(8):621-622.
  • Pasricha S, Durga G, Gupta G, Jajodia A, Koyyala VPB, Sharma A, Kamboj M, Gupta M, Mehta A. Primary Malignant Rhabdoid Tumour of the Liver in Adult Male: a Diagnostic and Therapeutic Challenge. J Gastrointest Cancer. 2020 Aug 13. doi: 10.1007/s12029-020-00474-0. Epub ahead of print. PMID: 32789765.
  • Goel S, Aggarwal A, Iqbal A, Gupta M, Rao A, Singh S. 18-FDG PET-CT should be included in preoperative staging of gall bladder cancer. Eur J Surg Oncol. 2020 Sep;46(9):1711-1716.
  • Gupta M, Karthikeyan G, Choudhury PS, Babu Koyyala VP, Sharma M, Jain P, Talwar V, Singh A, Rawal S. A Walk with Lu-177 PSMA: How Close we Have Reached from Bench to Bedside? Cancer Invest. 2020 Sep;38(8-9):486-492.
  • Doval DC, Tripathi R, Gupta M, Mehta A, Goyal P, Agrawal C, Jain S, Upreti K, Varghese S. Unusual case of ductal breast carcinoma with vulvar metastasis. Breast J. 2020 Nov;26(11):2255-2256.
  • Gupta M, Karthikeyan G, Choudhury PS, Sharma A, Rawal S. Clinical outcome of Lu-177 PSMA in metastatic castration-resistant prostate cancer: An initial experience from a tertiary care cancer hospital. Ann. Cancer Res. Ther. 2020 Dec; 28 (2):156-163.
  • Manoj Gupta, G Karthikeyan, Partha Sarathi Choudhury, Anurag Sharma, Amitabh Singh, Sudhir Rawal. Is 177Lu-PSMA an effective treatment modality for mCRPC patients with bone and visceral metastasis? Hell J Nucl Med. 2020 Sep-Dec;23(3):312-320.
  • Pasricha S, Bansal D, Batra U, Durga G, Kamboj M, Gupta G, Sharma A, Pahuja A, Jajodia A, Jain V, Gupta M, B Koyyala VP, Mehta A. Metastatic low-grade myoepithelial carcinoma of lung managed with low-dose external beam radiotherapy. Indian J Pathol Microbiol. 2021;64(1):155-157.
  • Gupta M, Choudhury PS, Singh A, Rawal S. Oligometastasis to testis in prostate cancer: Role of 68Ga-PSMA PET/CT. World J Nucl Med. 2021;20:113-6.
  • Pasricha S, Bansal D, Batra U, Durga G, Kamboj M, Gupta G, Sharma A, Pahuja A, Jajodia A, Jain V, Gupta M, B Koyyala VP, Mehta A. Metastatic low-grade myoepithelial carcinoma of lung managed with low-dose external beam radiotherapy. Indian J Pathol Microbiol. 2021;64:155-157.
  • Pasricha S, Durga G, Gupta G, Jajodia A, Koyyala VPB, Sharma A, Kamboj M, Gupta M, Mehta A. Primary Malignant Rhabdoid Tumour of the Liver in Adult Male: a Diagnostic and Therapeutic Challenge. J Gastrointest Cancer. 2021;52:738-741.
  • Mehta A, Diwan H, Bansal D, Gupta M. TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma. J Pathol Transl Med. 2021 Nov 16. doi: 10.4132/jptm.2021.09.16. Epub ahead of print.
  • Gupta M, Choudhury PS, Jain P, Sharma M, Koyyala VPB, Goyal S, Agarwal C, Jajodia A, Pasricha S, Sharma A, Batra U. Molecular Response Assessment with Immune Adaptive PERCIST in Lung Cancer Patients Treated with Nivolumab: Is It Better Than iRECIST? World J Nucl Med. 2022 Mar 9;21(1):34-43
  • Pasricha S, Sharma A, Pruthi M, Durga G, Jajodia A, Gupta G, Kamboj M, Gupta M, Mehta A. Multifocal primary pseudomyogenic hemangioendothelioma of bone managed with denosumab: A rare case with diagnostic and therapeutic challenge. J Cancer Res Ther. 2022 Apr- Jun;18(3):817-819.
  • Manoj Gupta, Sunil Pasricha, Rayaz Ahmed, Jeevitesh Khoda, and Partha Sarathi Choudhury. De Novo Extramedullary Plasmacytoma of Thyroid Cartilage. Clin Nucl Med. 2022 Dec 1;47(12):1089-1091.
  • Gupta Manoj, Pasricha Sunil, Ahmed Rayaz, Choudhury Partha Sarathi. A Case Series of Neurolymphomatosis: Role of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan Reiterated. Indian Journal of Nuclear Medicine. 2023 Jan–Mar;38(1):44-49.
  • Gupta Manoj, Jajodia Ankush, Ahlawat Parveen, Gairola Munish, Agarwal Mudit, Goyal Sumit, Mehta Parv, Choudhury Partha Sarathi. Effectiveness of Head-and-Neck Molecular Imaging Reporting and Data System Criterion in Head-and-Neck Squamous Cell Carcinoma Post Concurrent Chemoradiotherapy. Indian Journal of Nuclear Medicine. 2023;38(4):334-339.
  • Pasricha S, Durga G, Sharma A, Jajodia A, Singh S, Gupta G, Kamboj M, Koyyala VPB, Gupta M, Mehta A. Extranodal follicular dendritic cell sarcoma presenting as colonic mass: A diagnostic and therapeutic challenge. J Cancer Res Ther. 2024 Jan 1;20(1):450-453.
  • Pasricha S, Goyal S, Kamboj M, Diwan H, Gairola M, Sethi JS, Gupta M, Mehta A. Primary Oropharyngeal SMARCA4-Deficient Carcinoma: Expanding the Diagnostic Spectrum in Head and Neck Cancer. Head Neck Pathol. 2024 Mar 8;18(1):16.
  • Chadha P, Kamboj M, Pasricha S, Arora V, Yadav V, Gupta M, Mehta A. Spindle epithelial tumor with thymus-like elements (SETTLE): a diagnostic challenge with distinct therapeutic implication; case report. Diagn Pathol. 2024 Aug 13;19(1):108.
  • Ghose A, Banerjee S, Choudhury PS, Maniam A, Gupta M, Banna GL, Vasdev N, Ghose A, Noronha V, Mitra S. 177Lu-PSMA-617 for metastatic prostate cancer in India. Lancet Reg Health Southeast Asia. 2024 Sep 12;30:100484.
  • Naithani, Amita; Makkar, Priyanka1; Pratima, R2; Sharma, Anila3; Kamboj, Meenakshi4; Gupta, Manoj5; Jajodia, Ankush6; Agarwal, Vidushi7; Sekhon, Rupinder8. An aggressive recurrence of an early stage ovarian cancer? Second primary. Indian Journal of Cancer 61(3):p 622-625, Jul–Sep 2024.
  • Shreya Rai, Sunil Pasricha, Sarthak Tandon, Abhishek Singh, Ronak Bharadwaj, Manoj Gupta, Mudit Agarwal. The Fate of Oral Cavity Verrucous Hyperplasia in a Diagnostic Biopsy: A Conundrum for Subsequent Management. Indian J Surg Oncol (2025).
  • Tandon S, Ahlawat P, Mahajan S, Bellige A, Mishra S, Umesh P, Patodi V, Nayak A, Ansari A, Vyas H, Singh A, Rai S, Arora V, Yadav V, Pasricha S, Gupta M, Agarwal M, Dewan AK, Gairola M. Depth of Invasion as an Independent Indication for Postoperative Radiation Therapy in Oral Tongue Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2025 Apr 11:S0360- 3016(25)00361-X.
  • Arora V, Pasricha S, Kumar A, Kamboj M, Yadav V, Gupta M, Gupta G, Sharma A, Durga G, Gairola M, Goyal S, Mehta A. NUT carcinoma of larynx with aberrant LCA expression: A rare entity with diagnostic and therapeutic challenge. J Cancer Res Ther. 2025 Jan 1;21(1):311-314.

Chapter in Books:

  1. Case Based Reviews in Pediatric Endocrinology (First Edition 2015), Chapter No. 24: Nuclear Medicine Imaging in Pediatrics Endocrinology Publisher: Jaypee Brothers Medical
  1. Chapter No. 9.7 (b): Nuclear Medicine Imaging in Gynecological Malignancies (First Edition 2019), Editor in Chief: Dr. Sanchetee Suresh

Membership

  • Society of Nuclear Medicine India (SNMI)
  • Society of Nuclear Medicine and Molecular Imaging (SNMMI)
  • European Society of Nuclear Medicine (EANM)
  • World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)
  • European Society of medical Oncology (ESMO)
  • Radiological Society of North America (RSNA)